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Introduction: Region near the gene encoding methylenetetrahydrofolate reductase (MTHFR) is among eight 
loci associated with blood pressure.1-3 The aim of this study is to show connection between polymorphism of 
MTHFR C667T and hypertension, diabetes, prediabetes and obstructive sleep apnea in obese Croatian patients. 
Patients and Methods: We included 88 patients 
from a multidisciplinary weight management pro-
gram in which genetic analysis on MTHFR gene 
polymorphism was tested. Patients were divided 
in 3 groups: 36 patients with MTHFR C677T healthy 
genotype CC (27 women, 9 men; age 46.4±10.1 year; 
BMI 44.9±8.8 kg/m2), 38 patients with MTHFR 
C677T heterozygous mutation CT (27 women, 11 
men; age 46.9±11.4 year; BMI 44.6±8.6 kg/m2), 14 
patients with MTHFR C677T homozygous muta-
tion TT (12 women, 2 men; age 50.1±15.5 year; BMI 
40.2±6.9 kg/m2). In each group the incidence of hy-
pertension, prediabetes, diabetes and obstructive 
sleep apnea (OSA) was determined. 
Results: Patients with genetic mutation MTHFR 
C677T:CT (Figure 1) had the highest incidence of 
arterial hypertension (65.8%), diabetes (18.4%), pre-
diabetes (18.4%) and OSA (31.6%) with the highest 
average apnea hypopnea index (AHI) of 17.3±24.7, 
even 13.2% of patients used continuous positive 
airway pressure (CPAP). Patients with healthy 
genotype MTHFR C677T:CC had lower incidence 
of arterial hypertension (44.4%), prediabetes (11.1%), 
diabetes (13.9%), OSA (25%), average AHI 11.3±15.9 
and only 8% of patients used CPAP. Patients with 
MTHFR C677T:TT polymorphism had the lowest 
arterial hypertension incidence (42.9%), the high-
est prediabetes incidence (42.9%), middle OSA 
prevalence (28.6%), AHI 7.7±7.6. 
Conclusion: MTHFR C677T:CT polymorphism 
is the most common gene polymorphism in 
our group of morbidly obese patients. MTHFR 
C677T:CT polymorphism compared to MTHFR 
C677T:CC and MTHFR C677T:TT polymorphisms carries the highest risk for arterial hypertension, metabolic 
disorders (diabetes) and obstructive sleep apnea. Homozygotes MTHFR C677T:TT carries the highest risk for 
prediabetes. Further investigation is needed to explore this correlation. 
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Figure 1. the graph shows hypertension, prediabe-
tes and obstructive sleep apnea distribution in the 
group of patients with methylenetetrahydrofolate 
reductase cytosine-to-thymidine substitution at 
nucleotide 677 healthy genotype cc, heterozygous 
mutation ct and homozygous mutation tt. 
MTHFR C677T:CC - methylenetetrahydrofolate reductase 
cytosine-to-thymidine substitution at nucleotide 677 healthy 
genotype CC; MTHFR C677T:CT - methylenetetrahydrofolate 
reductase cytosine-to-thymidine substitution at nucleotide 
677 heterozygous mutation CT; MTHFR C677T:TT - methyle-
netetrahydrofolate reductase cytosine-to-thymidine substi-
tution at nucleotide 677 homozygous mutation TT.
